𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents

✍ Scribed by David P. Steensma

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
53 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Modification of gene expression: Help to
Modification of gene expression: Help to detect doping with erythropoiesis-stimulating agents
✍ Emmanuelle Varlet-Marie; Michel Audran; Michael Ashenden; Marie-ThΓ©rΓ¨se Sicart; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 642 KB

Enhanced oxygen delivery to tissues has been shown to improve endurance performance [1]. This has led to widespread abuse of erythropoiesis-stimulating agents (ESA) in elite sport. It is conceivable that athletes have even learned how to continue illicit ESA doping [2]. This possibility has fuelled

Expression and function of erythropoieti
Expression and function of erythropoietin receptors in tumors : Implications for the use of erythropoiesis-stimulating agents in cancer patients
✍ Angus M. Sinclair; Marque D. Todd; Kevin Forsythe; Susan J. Knox; Steve Elliott; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 323 KB

## Abstract Safety concerns surrounding the use of recombinant human erythropoietin (Epo) to treat anemia in cancer patients were raised after 2 recent clinical studies reported a worse survival outcome in patients who received epoetin Ξ± or epoetin Ξ² compared with patients who received placebo. Alt